Mapping of a quantitative trait locus for morphine withdrawal severity

Mammalian Genome

Volumn 15, Issue 8, 2004, Pages 610-617

  Kest, Benjamin ^a,b   Palmese, Christina A ^b   Juni, Aaron ^b   Chesler, Elissa J ^c   Mogil, Jeffrey S ^d  

^a CITY UNIVERSITY OF NEW YORK   (United States)

^b CITY UNIVERSITY OF NEW YORK   (United States)

^c UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^d MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MORPHINE SULFATE; NALOXONE;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHROMOSOME 1; CHROMOSOME 10; CHROMOSOME 5; CONTROLLED STUDY; DISSOCIATION; DOSE RESPONSE; DRUG DOSE REGIMEN; DRUG POTENCY; DRUG WITHDRAWAL; FEMALE; GENE FREQUENCY; GENE LOCUS; GENE MAPPING; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC SCREENING; GENETIC VARIABILITY; MALE; MICROSATELLITE MARKER; MORPHINE ADDICTION; MORPHINE TOLERANCE; MOUSE; NONHUMAN; PHENOTYPIC VARIATION; PLEIOTROPY; QUANTITATIVE TRAIT LOCUS;

ANALGESICS, OPIOID; ANIMALS; DRUG TOLERANCE; FEMALE; LOD SCORE; MALE; MICE; MORPHINE; MORPHINE DEPENDENCE; QUANTITATIVE TRAIT LOCI; SUBSTANCE WITHDRAWAL SYNDROME;

ANIMALIA;

EID: 3943098597     PISSN: 09388990     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00335-004-2367-3     Document Type: Article

References (37)

1. Belknap JK, Mogil JS, Helms ML, Richards SP, O'Toole LA, et al. (1995) Localization to chromosome 10 of a locus influencing morphine-induced antinociception in crosses derived from C57BL/6 and DBA/2 mice. Life Sci 57, PL117-PL124
2. Belzung C, Griebel G (2001) Measuring normal and pathological anxiety-like behaviour in mice: a review. Behav Brain Res 125, 141-149
3. Bergeson SE, Helms ML, O'Toole LA, Jarvis MW, Hain HS, et al. (2001) Quantitative trait loci influencing morphine antinociception in four mapping populations. Mamm Genome 12, 546-553
4. Berrettini WH, Ferraro TN, Alexander RC, Buchberg AM, Vogel WH (1994) Quantitative trait loci mapping of three loci controlling morphine preference using inbred mouse strains. Nat Genet 7, 54-58
5. Broman KW, Wu H, Sen S, Churchill GA (2003) R/qtl: QTL mapping in experimental crosses. Bioinformatics 19, 889-890
6. Buck KJ, Metten P, Belknap JK, Crabbe JC (1997) Quantitative trait loci involved in genetic predisposition to acute alcohol withdrawal in mice. J Neurosci 15, 3946-3955
7. Buck K, Metten P, Belknap J, Crabbe J (1999) Quantitative trait loci affecting risk for pentobarbital withdrawal map near alcohol withdrawal loci on mouse chromosomes 1, 4, and 11. Mamm Genome 10, 431-437
8. Cao JL, Ding HL, Zhang LC, Duan SM, Zeng YM (2002) Pretreatment with midazolam suppresses morphine withdrawal response in mice and rats. Acta Pharmacol Sin 23, 685-690
9. Christrup LL (1997) Morphine metabolites. Acta Anaesthesiol Scand 41, 116-122
10. Churchill GA, Doerge RW (1994) Empirical threshold values for quantitative trait mapping. Genetics 138, 963-971
11. Contet C, Rawlins JN, Deacon RM (2001) A comparison of 129S2/SvHsd and C57BL/6JO1aHsd mice on a test battery assessing sensorimotor, affective and cognitive behaviours: implications for the study of genetically modified mice. Behav Brain Res. 124, 33-46
12. Crain SM, Shen K (2000) Enhanced analgesic potency and reduced tolerance of morphine in 129/SvEv mice: evidence for a deficiency in GM1 ganglioside-regulated excitatory opioid receptor functions. Brain Res 21, 227-235
13. Fisher MB, Vandenbranden M, Findlay K, Burchell B, Thummel KE, et al. (2000) Tissue distribution and interindividual variation in human UDP-glucuronosyltransferase activity: relationship between UGT1A1 promoter genotype and variability in a liver bank. Pharmacogenomics 10, 727-739
14. Fritschy JM, Brunig I (2003) Formation and plasticity of GABAergic synapses: physiological mechanisms and pathophysiological implications. Pharmacol Ther 98, 299-323
15. Hegmann JP, Possidente B (1981) Estimating genetic correlations from inbred strains. Behav Genet 11, 103-114
16. Herman BH, Vocci F, Bridge P (1995) The effects of NMDA receptor antagonists and nitric oxide synthase inhibitors on opioid tolerance and withdrawal. Medication development issues for opiate addiction. Neuropsychopharmacology 13, 269-293
17. Kavaliers M, Hirst M (1983) Daily rhythms of analgesia in mice: effects of age and photoperiod. Brain Res. 279, 387-393
18. Kelly MA, Low MJ, Phillips TJ, Wakeland EK, Yanagisawa M (2003) The mapping of quantitative trait loci underlying strain differences in locomotor activity between 129S6 and C57BL/6J mice. Mamm Genome 14, 692-702
19. Kest B, McLemore GL, Sadowski B, Mogil JS, Belknap JK, et al. (1998) Acute morphine dependence in mice selectively-bred for high and low analgesia. Neurosci Lett 256, 120-122
20. Kest B, Palmese CA, Hopkins E, Adler M, Juni A (2001) Assessment of acute and chronic morphine dependence in male and female mice. Pharmacol Biochem Behav 70, 1-8
21. Kest B, Hopkins E, Palmese C, Adler M, Mogil S (2002a) Genetic variation in morphine analgesic tolerance: a survey of 11 inbred mouse strains. Pharmacol Biochem Behav 73, 821-828
22. Kest B, Palmese C, Hopkins E, Adler M, Juni A, et al. (2002b) Naloxone-precipitated withdrawal jumping in 11 inbred mouse strains: evidence for common genetic mechanisms in acute and chronic morphine physical dependence. Neuroscience 115, 463-469
23. Kolesnikov Y, Jain S, Wilson R, Pasternak GW (1998) Lack of morphine and enkephalin tolerance in 129/SvEv mice: Evidence for a NMDA receptor defect. J Pharmacol Exp Ther 284, 455-459
24. Lander E, Kruglyak L (1995) Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet 11, 241-247
25. Mackenzie PI, Hjelmeland LM, Owens IS (1984) Purification and immunochemical characterization of a low-pI form of UDP glucuronosyltransferase from mouse liver. Arch Biochem Biophys 231, 487-497
26. Manly KF, Olson JM (1999) Overview of QTL mapping software and introduction to map manager QT. Mamm Genome 10, 327-334
27. Mayer DJ, Mao J, Price DD (1995) The development of morphine tolerance and dependence is associated with translocation of protein kinase C. Pain 61, 365-374
28. Miyamoto Y, Takemori AE (1993) Relative involvement of supraspinal and spinal mu opioid receptors in morphine dependence in mice. Life Sci 52, 1039-1044
29. Mogil JS, Wilson SG (1997) Nociceptive and morphine antinociceptive sensitivity of 129 and C57BL/6 inbred mouse strains: implications for transgenic knock-out studies. Eur J Pain 1, 293-297
30. Nestler EJ, Aghajanian GK (1997) Molecular and cellular bases of addiction. Science 278, 58-66
31. Pasternak GW (2001) Insights into mu opioid pharmacology: the role of mu opioid receptor subtypes. Life Sci 6, 2213-2219
32. Pellegrini-Giampietro DE, Ruggiero M, Giannelli S, Chiarugi VP, Moroni F (1988) Morphine withdrawal in vitro: potentiation of agonist-dependent polyphosphoinositide breakdown. Eur J Pharmacol 149, 297-306
33. Rodgers RJ, Boullier E, Chatzimichalaki P, Cooper GD, Shorten A (2002) Contrasting phenotypes of C57BL/6JO1aHsd, 129S2/SvHsd and 129/SvEv mice in two exploration-based tests of anxiety-related behaviour. Physiol Behav 77, 301-310
34. Simpson EM, Linder CC, Sargent EE, Davisson MT, Mobraaten LE, et al. (1997) Genetic variation among 129 substrains and its importance for targeted mutagenesis in mice. Nat Genet 16, 19-27
35. Smith FL, Lohmann AB, Dewey WL (1999) Involvement of phospholipid signal transduction pathways in morphine tolerance in mice. Br J Pharmacol 128, 220-226
36. Suzuki T, Tsuda M, Narita M, Funada M, Mizoguchi H, et al. (1996) Diazepam pretreatment suppresses morphine withdrawal signs in the mouse. Life Sci 58, 349-357
37. Voikar V, Koks S, Vasar E, Rauvala H (2001) Strain and gender differences in the behavior of mouse lines commonly used in transgenic studies. Physiol Behav 72, 271-281